LUCIA SALDANA: Open Payments
NPI 1316071335 · MISSION, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,591 in 78 payments from 17 companies in 2025. Trend: 2023 $1,462 · 2024 $1,717 · 2025 $1,591
Food & beverage: $1,591
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $367 |
| Novo Nordisk Inc | 15 | $220 |
| Abbott Laboratories | 4 | $161 |
| Lilly USA, LLC | 6 | $142 |
| GlaxoSmithKline, LLC. | 4 | $111 |
| Sumitomo Pharma America, Inc. | 4 | $106 |
| PFIZER INC. | 4 | $100 |
| AstraZeneca Pharmaceuticals LP | 5 | $83 |
| Astellas Pharma US Inc | 4 | $65 |
| Phathom Pharmaceuticals, Inc. | 2 | $44 |
Products named: FREESTYLE LIBRE 3, LINZESS, JARDIANCE, TRELEGY ELLIPTA, GEMTESA, UBRELVY, Wegovy, Ozempic.
Industry payments across TX — which companies pay providers there.
